Comparison to the advanced PCa cohort from our previous study [19] revealed a higher rate of the DDR gene (BRCA1/BRCA2/ATM/CHEK2) mutations in the localized PCa than in the advanced disease (16.8% vs. 14.8%, p = 0.70). The gene discussed is CHEK2; the disease is posterior cortical atrophy.